Richard D. Cherney
Director/Miembro de la Junta en Benvest Holdings Ltd. .
Cargos activos de Richard D. Cherney
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Davies Ward Phillips & Vineberg LLP
Davies Ward Phillips & Vineberg LLP Miscellaneous Commercial ServicesCommercial Services Davies Ward Phillips & Vineberg LLP provides legal services. It offers services to industries, commercial companies and financial institutions. The company's clients include government, regulatory bodies, charitable organizations, international agencies, educational institutions, individuals and trusts & estates. It was founded in February 2002 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01/01/1985 | - |
Benvest Holdings Ltd. | Director/Miembro de la Junta | - | - |
eStruxture Data Centers, Inc.
eStruxture Data Centers, Inc. Financial ConglomeratesFinance eStruxture Data Centers, Inc. engages in the provision of data services. It offers colocation, cloud, network, virtual servers, managed hosting, storage, backup, and disaster recovery. The company is headquartered in Montr?al, Canada. | Director/Miembro de la Junta | - | - |
MacKinnon, Bennett & Co., Inc.
MacKinnon, Bennett & Co., Inc. Investment ManagersFinance MacKinnon, Bennett & Co., Inc. (MKB) is an independent private equity firm founded in 2007 by Kenneth MacKinnon and William John Bennett. The firm is headquartered in Montreal, Canada. | Director/Miembro de la Junta | - | - |
Addénergie Technologies, Inc.
Addénergie Technologies, Inc. Wholesale DistributorsDistribution Services Addénergie Technologies, Inc. operates electric vehicle charging stations. It develops, manufactures and operates charging solutions for all market segments such as the public sector, employers, multi-residential, fleets and residential. The company was founded by Louis Tremblay in 2009 and is headquartered in Québec, Canada. | Director/Miembro de la Junta | 14/03/2022 | - |
ExCellThera, Inc.
ExCellThera, Inc. BiotechnologyHealth Technology ExCellThera, Inc. is a world leader in blood stem cell expansion and rejuvenation. The private company is based in Montréal, Canada. The Canadian company's proprietary molecule, UM171, is the standard for hematopoietic stem cell expansion in cell and gene therapy. UM171 has a first-in-class mechanism of action that expands and rejuvenates HSCs, and counteracts exhaustion from culture and gene modification, which are important limitations in cell and gene therapies. ExCellThera has developed commercial GMP grade UM171, which can be integrated into the manufacturing process of various cell and gene therapy products as a reagent and is supported by a Type II Drug Master File (DMF) filed with the FDA. ExCellThera was founded in 2013 by Peter Zandstra and Guy Sauvageau. Guy Sauvageau has been the CEO since 2013. | Director/Miembro de la Junta | - | - |
Historial de carrera de Richard D. Cherney
Antiguos cargos conocidos de Richard D. Cherney.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KANE BIOTECH INC. | Director/Miembro de la Junta | 29/06/2011 | 08/10/2014 |
Independent Dir/Board Member | 29/06/2011 | 08/10/2014 | |
LE CHÂTEAU INC. | Director/Miembro de la Junta | 01/01/2005 | 08/07/2011 |
Benvest New Look Income Fund
Benvest New Look Income Fund Investment Trusts/Mutual FundsMiscellaneous Benvest New Look Income Fund provides eye care products and services and merchant banking services. It operates through two segments namely Eye Care and Merchant Banking. It operates in its optical business through Lunetterie New Look International, Inc. in Canada. The products of the Group include opthalmic frames, lenses and related services. It was founded in 2005 and is headquartered in Montreal, Canada. | Director/Miembro de la Junta | 01/05/2005 | 04/03/2010 |
Secretario Corporativo | 01/05/2005 | 04/03/2010 | |
░░░ ░░░░ ░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░ ░░░░ ░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Richard D. Cherney.
Concordia University | Undergraduate Degree |
McGill University | Graduate Degree |
Estadísticas
Internacional
Canadá | 15 |
Operativa
Director/Board Member | 10 |
Corporate Secretary | 3 |
Independent Dir/Board Member | 2 |
Sectorial
Finance | 4 |
Commercial Services | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
KANE BIOTECH INC. | Commercial Services |
Empresas privadas | 11 |
---|---|
Le Château, Inc.
Le Château, Inc. Apparel/Footwear RetailRetail Trade Le Château, Inc. operates as a Canadian retailing brand. It engages in the retail of apparel, accessories and footwear. The firm markets its products under the brand name Le Château, which is designed and developed within its vertically integrated operations. The company was founded by Herschel H. Segal on April 5, 1987 and is headquartered in Mount-Royal, Canada. | Retail Trade |
Davies Ward Phillips & Vineberg LLP
Davies Ward Phillips & Vineberg LLP Miscellaneous Commercial ServicesCommercial Services Davies Ward Phillips & Vineberg LLP provides legal services. It offers services to industries, commercial companies and financial institutions. The company's clients include government, regulatory bodies, charitable organizations, international agencies, educational institutions, individuals and trusts & estates. It was founded in February 2002 and is headquartered in Toronto, Canada. | Commercial Services |
Benvest New Look Income Fund
Benvest New Look Income Fund Investment Trusts/Mutual FundsMiscellaneous Benvest New Look Income Fund provides eye care products and services and merchant banking services. It operates through two segments namely Eye Care and Merchant Banking. It operates in its optical business through Lunetterie New Look International, Inc. in Canada. The products of the Group include opthalmic frames, lenses and related services. It was founded in 2005 and is headquartered in Montreal, Canada. | Miscellaneous |
New Look Eyewear, Inc. /Old/ | |
Benvest Capital, Inc. | Finance |
New Look Vision Group, Inc.
New Look Vision Group, Inc. Medical DistributorsDistribution Services New Look Vision Group, Inc. engages in the eye care retail activities. Its categories of optical products include prescription and non-prescription eyewear; contact lenses; sunglasses, protective eyewear, and reading glasses; and accessories. The company was founded in 1986 and is headquartered in Montréal, Canada. | Distribution Services |
Benvest Holdings Ltd. | |
eStruxture Data Centers, Inc.
eStruxture Data Centers, Inc. Financial ConglomeratesFinance eStruxture Data Centers, Inc. engages in the provision of data services. It offers colocation, cloud, network, virtual servers, managed hosting, storage, backup, and disaster recovery. The company is headquartered in Montr?al, Canada. | Finance |
MacKinnon, Bennett & Co., Inc.
MacKinnon, Bennett & Co., Inc. Investment ManagersFinance MacKinnon, Bennett & Co., Inc. (MKB) is an independent private equity firm founded in 2007 by Kenneth MacKinnon and William John Bennett. The firm is headquartered in Montreal, Canada. | Finance |
Addénergie Technologies, Inc.
Addénergie Technologies, Inc. Wholesale DistributorsDistribution Services Addénergie Technologies, Inc. operates electric vehicle charging stations. It develops, manufactures and operates charging solutions for all market segments such as the public sector, employers, multi-residential, fleets and residential. The company was founded by Louis Tremblay in 2009 and is headquartered in Québec, Canada. | Distribution Services |
ExCellThera, Inc.
ExCellThera, Inc. BiotechnologyHealth Technology ExCellThera, Inc. is a world leader in blood stem cell expansion and rejuvenation. The private company is based in Montréal, Canada. The Canadian company's proprietary molecule, UM171, is the standard for hematopoietic stem cell expansion in cell and gene therapy. UM171 has a first-in-class mechanism of action that expands and rejuvenates HSCs, and counteracts exhaustion from culture and gene modification, which are important limitations in cell and gene therapies. ExCellThera has developed commercial GMP grade UM171, which can be integrated into the manufacturing process of various cell and gene therapy products as a reagent and is supported by a Type II Drug Master File (DMF) filed with the FDA. ExCellThera was founded in 2013 by Peter Zandstra and Guy Sauvageau. Guy Sauvageau has been the CEO since 2013. | Health Technology |
- Bolsa de valores
- Insiders
- Richard D. Cherney
- Experiencia